Major advances in the treatment of aggressive NHL have occurred in the last 20 years.
Modern combination chemotherapy provides a complete remission in a majority of patients …

Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and
clinical behavior. Patients typically present with persistent painless lymphadenopathy, but …

PURPOSE A single-center, prospective, nonrandomized trial was conducted to evaluate
therapeutic results of a short-term program of chemotherapy followed by locoregional …

Once the diagnosis of a non-Hodgkin's lymphoma (NHL) has been established three critical
steps in patient management must follow. The first is the pre-treatment evaluation and …

With currently available combination chemotherapy regimens, the outcome of the patients
newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified as 'high'and …

In a consecutive series of 113 patients with localized (Stage I and II) intermediate and high
grade non-Hodgkin's lymphoma we have retrospectively analysed patterns of survival and …

Non-Hodgkin lymphomas are a heterogeneous group of malignancies of the lymphoid
system. Based on the World Health Organization classification of hematological and …

Since the introduction of the Working Formulation for Clinical Usage, 3 different prognostic
groups are recognized among the various histological classifications of non‐Hodgkin's …

In an attempt to evaluate natural history, prognostic factors and survival, the data of 340
patients with NHL were collected. 267 patients were evaluable for the analysis of prognostic …

Low-grade non-Hodgkin's lymphomas are characterized by a low proliferative activity and
prolonged clinical course. Most of them reveal distinct cytogenetic and molecular …